Rocket Pharmaceuticals, Inc. (RCKT) Debt Components
- 2021-12-31: Convertible Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, CurrentUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2021-09-30: Convertible Notes Payable, CurrentUSD $0.00; Notes Payable to Bank, CurrentUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2021-06-30: Convertible Notes Payable, CurrentUSD $5.10M; Notes Payable to Bank, CurrentUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
- 2021-03-31: Convertible Notes Payable, CurrentUSD $4.99M; Notes Payable to Bank, CurrentUSD (m); Debt Instrument, Unamortized DiscountUSD (m).
Rocket Pharmaceuticals, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Convertible Notes Payable, Current USD | Notes Payable to Bank, Current USD | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|
| 2021-12-31 | $0.00 | (m) | (m) |
| 2021-09-30 | $0.00 | (m) | (m) |
| 2021-06-30 | $5.10M | (m) | (m) |
| 2021-03-31 | $4.99M | (m) | (m) |
| 2020-12-31 | $4.88M | (m) | (m) |
| 2020-09-30 | $4.76M | (m) | (m) |
| 2019-12-31 | $0.00 | (m) | (m) |
| 2015-06-30 | (m) | (m) | $12.07M |
| 2015-03-31 | (m) | (m) | $12.33M |
| 2014-12-31 | $1.54M | $3.06M | (m) |
| 2014-12-31 | (m) | (m) | $12.07M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |